Related Experiment Video
Updated: Jan 29, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.5K
Type 2 diabetes mellitus and osteoarthritis
Nicola Veronese1, Cyrus Cooper2, Jean-Yves Reginster3
1National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy.
Seminars in Arthritis and Rheumatism
|February 5, 2019
Summary
Type 2 diabetes (T2DM) promotes osteoarthritis (OA) through inflammation and oxidative stress, independent of weight. Careful medication selection is crucial for treating OA in T2DM patients.
Area of Science:
- Endocrinology
- Rheumatology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) frequently coexist, with overweight/obesity often implicated.
- The independent contribution of T2DM to OA pathophysiology and outcomes, beyond mechanical factors, warrants investigation.
Purpose of the Study:
- To review the association between T2DM and OA, considering site-specificity and impact on OA outcomes.
- To assess the safety of anti-OA treatments in patients with T2DM.
Main Methods:
- Critical literature review.
- Exploration of T2DM's role in OA pathophysiology.
- Assessment of anti-OA medication safety in T2DM patients.
Main Results:
- T2DM contributes to OA via oxidative stress and chronic inflammation from hyperglycemia and insulin resistance.
- T2DM is a risk factor for OA progression and negatively affects arthroplasty outcomes.
- Safety concerns exist for common OA medications (paracetamol, NSAIDs, corticosteroids); glucosamine and hyaluronic acid appear safer.
Conclusions:
- Further research is needed to determine if diabetes management influences OA occurrence and progression.
- Therapeutic strategies for OA in T2DM patients require careful evidence-based selection to mitigate safety risks.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K
01:20Pathophysiology of Diabetes
3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:19Psychoneuroimmunology: Diabetes and Cancer
498
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
498
01:13meta-Directing Deactivators: –NO2, –CN, –CHO, –CO2R, –COR, –CO2H
6.7K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.7K